Skip to main content

West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75

WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.